Millennium Management LLC trimmed its position in shares of Cerecor Inc (NASDAQ:CERC) by 78.0% in the fourth quarter, HoldingsChannel.com reports. The firm owned 13,762 shares of the company’s stock after selling 48,703 shares during the period. Millennium Management LLC’s holdings in Cerecor were worth $44,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors have also recently bought and sold shares of CERC. Vanguard Group Inc grew its position in shares of Cerecor by 10.1% during the 3rd quarter. Vanguard Group Inc now owns 87,929 shares of the company’s stock valued at $411,000 after acquiring an additional 8,094 shares during the period. BlackRock Inc. grew its position in shares of Cerecor by 18.5% during the 4th quarter. BlackRock Inc. now owns 33,960 shares of the company’s stock valued at $109,000 after acquiring an additional 5,293 shares during the period. Northern Trust Corp grew its position in shares of Cerecor by 47.9% during the 4th quarter. Northern Trust Corp now owns 20,079 shares of the company’s stock valued at $65,000 after acquiring an additional 6,500 shares during the period. Geode Capital Management LLC grew its position in shares of Cerecor by 50.7% during the 4th quarter. Geode Capital Management LLC now owns 94,990 shares of the company’s stock valued at $306,000 after acquiring an additional 31,951 shares during the period. Finally, Prosight Management LP acquired a new stake in shares of Cerecor during the 4th quarter valued at about $994,000. 50.28% of the stock is owned by hedge funds and other institutional investors.
NASDAQ:CERC opened at $5.37 on Friday. Cerecor Inc has a 52 week low of $2.71 and a 52 week high of $7.65. The company has a quick ratio of 0.91, a current ratio of 0.95 and a debt-to-equity ratio of 0.62.
In other news, major shareholder Armistice Capital Master Fund acquired 374,486 shares of the stock in a transaction that occurred on Friday, March 8th. The shares were bought at an average cost of $5.50 per share, for a total transaction of $2,059,673.00. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Armistice Capital, Llc acquired 125,486 shares of the stock in a transaction that occurred on Wednesday, March 6th. The stock was purchased at an average price of $5.50 per share, for a total transaction of $690,173.00. The disclosure for this purchase can be found here. Over the last quarter, insiders purchased 618,825 shares of company stock worth $3,377,503. 80.20% of the stock is currently owned by insiders.
A number of equities research analysts have recently commented on CERC shares. TheStreet upgraded Cerecor from a “d” rating to a “c-” rating in a research report on Wednesday, January 30th. ValuEngine cut Cerecor from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 8th. BidaskClub upgraded Cerecor from a “buy” rating to a “strong-buy” rating in a research report on Friday, March 1st. HC Wainwright started coverage on Cerecor in a research report on Monday, April 1st. They set a “buy” rating and a $11.00 target price on the stock. Finally, Maxim Group started coverage on Cerecor in a research report on Tuesday, April 9th. They set a “buy” rating and a $10.00 target price on the stock. Four research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. Cerecor currently has a consensus rating of “Buy” and an average price target of $9.67.
ILLEGAL ACTIVITY NOTICE: “Millennium Management LLC Has $44,000 Holdings in Cerecor Inc (CERC)” was first posted by Week Herald and is the sole property of of Week Herald. If you are accessing this report on another website, it was stolen and reposted in violation of US & international copyright laws. The legal version of this report can be viewed at https://weekherald.com/2019/05/19/millennium-management-llc-has-44000-holdings-in-cerecor-inc-cerc.html.
Cerecor Company Profile
Cerecor Inc, a pharmaceutical company, focuses on pediatric health care. Its lead product portfolio includes prescribed dietary supplements, such as Poly-Vi-Flor and Tri-Vi-Flor; and prescription drugs, such as Millipre, Ulesfia, Karbinal ER, AcipHex Sprinkle, and Cefaclor for oral suspension, as well as Flexichamber a medical device.
Read More: Exchange-Traded Funds (ETFs)
Want to see what other hedge funds are holding CERC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerecor Inc (NASDAQ:CERC).
Receive News & Ratings for Cerecor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerecor and related companies with MarketBeat.com's FREE daily email newsletter.